By Alice Klein Empty stands at a football match warm-up in Jeonju, South Korea, on 8 May 2020UNG YEON-JE/AFP via Getty Images Lockdowns to contain the coronavirus led to drastic reductions in the vibrations of Earth’s surface, as people significantly curtailed their activity. Seismologists measure vibrations from earthquakes that travel through Earth’s surface. Their instruments…
A worker wipes down surfaces on a New York City subway car to disinfect seats during the coronavirus outbreak. The CDC is clarifying its guidance on touching surfaces after a change to its website triggered news reports. Andrew Kelly/Reuters hide caption toggle caption Andrew Kelly/Reuters A worker wipes down surfaces on a New York City…
A specially formulated antimicrobial coating can keep surfaces clear of a human coronavirus for up to 90 days with just one application, a preliminary study said Friday, suggesting a new line of defense against COVID-19. The paper by researchers at the University of Arizona (UA), which has not yet been peer-reviewed, found that the amount…
Robert F. Kennedy Jr. has rightly made “radical transparency” the motto of his Department of Health and Human Services. HHS even has a page by that name. I think it is a good motto, and I want to help Secretary Kennedy and Acting FDA Commissioner Kyle Diamantas deliver on it in food safety, with two citizen petitions
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment